⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17522636 | 0.86 | — | — | |
| SCHEMBL13912609 | 0.84 | — | — | |
| SCHEMBL19296362 | 0.82 | — | — | |
| SCHEMBL23571684 | 0.82 | — | — | |
| SCHEMBL15841346 | 0.82 | MEN1 (0.35) | — | |
| SCHEMBL15889133 | 0.79 | NAAA (0.37) | — | |
| SCHEMBL16772185 | 0.78 | EPHX2 (0.37) | — | |
| SCHEMBL24452383 | 0.78 | EPHX2 (0.37) | — | |
| SCHEMBL12465815 | 0.77 | — | — | |
| SCHEMBL17284109 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617905-B2 | Crosslinked alginic acid | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20240342340-A1 | MULTILAYER STRUCTURE USING CHEMICALLY CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2024-10-17 | — | — | US | disclosed |
| CN-117042782-A | Multilayer structure using chemically crosslinked alginic acid | 持田制药株式会社 | 2023-11-10 | — | — | CN | disclosed |
| US-20230035986-A1 | NOVEL CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| CN-114929754-A | Novel cross-linked alginic acid | 持田制药株式会社 | 2022-08-19 | — | — | CN | disclosed |